Increasing Legislative and Legal Amendments to Help Drive Global Medical Cannabis Market Growth to Valuation of worth US$53 Bn by 2027, finds TMR

ALBANY, New York, June 2, 2020 /PRNewswire/ -- TMR has now come up with a market research report that offers great insights about the overall working dynamics of the global medical cannabis market. The research report tries to shed light on the key segments influencing the market growth, driving and restraining factors, geographical outlook, and the overall situation of the competitive landscape.

https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg

According to the research report, the global medical cannabis, the market is projected to witness a massive CAGR of 27% over the course of the given forecast period ranging from 2019 to 2027. The valuation of the global market was around US$8 Bn in 2018. Given the rate of growth, the market is projected to experience a massive surge in valuation and reach worth around US$53 Bn by the fall of 2027.

Download a PDF Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76890

Global Medical Cannabis Market - Key Takeaways

    --  Based on derivative, the global market for medical cannabis is segmented
        into tetrahydrocannabinol (THC), cannabidiol (CBD), and others.
    --  In terms of applications, the global market is segmented into pain
        management, neurological disorders management, and mental health
        management. Of these, the segments of pain management and mental health
        management are expected to witness significant growth in the coming
        years of the forecast period.
    --  Based on the route of administration, the market is segmented into oral,
        nasal, and others such as cannabis oil, soft gels, etc. Of these, the
        oral segment is expected to gather momentum in the coming years of the
        forecast period.
    --  In terms of distribution channels, the market is segmented into online
        pharmacies, retail pharmacies, and hospital pharmacies. Of these, the
        segment of retail pharmacies has been the dominant one and will continue
        to lead in the near future.

Explore a report with detailed research, incisive insights, and in-depth country levels estimations. Gain business intelligence on global Medical Cannabis Market (Derivative: Cannabidiol [CBD], Tetrahydrocannabinol [THC], and Others; Application: Mental Health Management, Neurological Disorders Management, and Pain Management; Route of Administration: Nasal, Oral, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 - https://www.transparencymarketresearch.com/report-toc/76890

Global Medical Cannabis Market - Key Driving Factors

    --  The overall growth of the global medical cannabis market is a result of
        economic, social, and political change of interests happening across the
        globe. Currently, around 30 nations have legalized the use of medical
        cannabis and cannabis extracts for therapeutic applications. And it is
        projected that this trend will continue to gain momentum in the coming
        years of the forecast period.
    --  With the growing trend of decriminalizing cannabis and issuing strict
        mandates for regulated use of the product, the governments have
        witnessed a massive rise in their revenues. This is expected to
        encourage other countries and thus help the development of the market in
        the coming years of the forecast period.
    --  Increasing research and studies showing positive results and benefits of
        use of medical cannabis have also helped in fueling the growth of the
        global market.

Analyze Medical Cannabis Market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea.

Inquire for a Sample Copy of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76890

Global Medical Cannabis Market - Key Restraining Factors

    --  Covid-19 has had a largescale impact on the overall development of the
        global market. The consumption patterns of medical cannabis are expected
        to witness slight decline in the second quarter of 2020.
    --  Another important challenge for the market growth has been streamlining
        of supply lines post Covid-19 situations.

Global Medical Cannabis Market - Geographical Outlook

    --  North America is expected to emerge as the most dominant segment of the
        global medical cannabis market. The US and Canada are projected to
        contribute significantly in the growth of the regional market due to
        high levels of consumption.
    --  The regional segment of Europe is also expected to witness a similarly
        promising growth due to increasing number of nations sanctioning partial
        or full use of medical cannabis.

Global Medical Cannabis Market - Key Players

Canopy Growth Corporation, United Cannabis, Aurora Cannabis, Cannabis Sativa, Inc., Emerald Health Therapeutics, and GW Pharmaceuticals plc among others are some of the notable names in the global market.

Purchase the Medical Cannabis Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=76890&ltype=S

Global Medical Cannabis Market: Research Scope

Medical Cannabis Market, by Derivative

    --  Cannabidiol (CBD)
    --  Tetrahydrocannabinol (THC)
    --  Others

Medical Cannabis Market, by Application

    --  Mental Health Management
        --  Anxiety
        --  Depression
        --  Others (attention deficit hyperactivity disorder (ADHD),
            post-traumatic stress disorder, etc.)
    --  Neurological Disorders Management
        --  Epilepsy
        --  Alzheimer's Disease
        --  Parkinson's Disease
        --  Others (Huntington's disease, multiple sclerosis, etc.)
    --  Pain Management
        --  Neuropathic Pain
        --  Cancer Pain
        --  Others (post-operative, chronic pain, etc.)

Medical Cannabis Market, by Route of Administration

    --  Nasal
    --  Oral
    --  Others

Medical Cannabis Market, by Distribution Channel

    --  Hospital Pharmacies
    --  Retail Pharmacies
    --  Online Pharmacies

Medical Cannabis Market, by Region

    --  North America
        --  U.S.
        --  Canada
    --  Europe
        --  Germany
        --  France
        --  U.K.
        --  Italy
        --  Spain
        --  Rest of Europe
    --  Latin America
        --  Brazil
        --  Mexico
        --  Rest of Latin America
    --  Rest of the World

Explore Transparency Market Research's award-winning coverage of the global Healthcare industry:

Ventilator-associated Pneumonia (VAP) Market - Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has risen to 20% to 30%. The incidence rate of VAP depends on many factors including reintubation, age & altered consciousness, duration of mechanical ventilation, and supine position. Early and precise diagnosis of VAP is tough and there is an urgent need of an optimal antibiotic treatment.

Pneumonia Drugs & Vaccines Market - Pneumonia is a common lung infection caused by a variety of microorganisms such as bacteria, virus, fungi and parasites. In pneumonia the air sacs of lungs that are known as alveoli are filled with fluid or pus causing inflammation. The common symptoms of pneumonia are cough with phlegm, sneezing, sore throat, chills, fever and trouble in breathing. Pneumonia is usually a mild disease but under certain situations can be lethal. Children, elderly people and those with recent viral infections, lung disease and heart disease are at higher risk of developing pneumonia compared to general population. Pneumonia is of different types depending on the way it has been acquired by people such community acquired pneumonia (CAP), hospital acquired pneumonia (HAP) and healthcare associated pneumonia as patient may also develop pneumonia during their visits to other healthcare setting such as nursing homes, dialysis centers and outpatient clinics. Others are aspiration pneumonia and atypical pneumonia. Pneumonia is one of the most common hospital acquired infection.

Airway/Lung Stent Market - According to a study by Transparency Market Research (TMR), the global market for airway/lung stents is likely to experience steady growth, increasing to 5.7% CAGR during 2017-2026. The global market for airway/lung stent is also estimated to bring in US$ 130.4 million revenue by 2026 end.

Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

View original content:http://www.prnewswire.com/news-releases/increasing-legislative-and-legal-amendments-to-help-drive-global-medical-cannabis-market-growth-to-valuation-of-worth-us53-bn-by-2027-finds-tmr-301069367.html

SOURCE Transparency Market Research